Loading clinical trials...
Loading clinical trials...
RIVA-PSP: Efficacy of Rivastigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy: A Randomised Double Blind Placebo-controlled Clinical Trial
Conditions
Interventions
Rivastigmine
Placebo
Locations
1
France
Service de Neurologie et Pathologie du Mouvement Hôpital de La Timone
Marseille, France
Start Date
July 26, 2016
Primary Completion Date
June 3, 2022
Completion Date
November 17, 2022
Last Updated
July 20, 2023
NCT05121012
NCT07136844
NCT02365922
NCT03391765
NCT02778607
NCT02531360
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions